Published in Nat Commun on December 07, 2015
Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells. Nature (2017) 1.43
Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair. Cell (2016) 1.08
Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors. Nat Genet (2016) 0.86
Integrative systems medicine approaches to identify molecular targets in lymphoid malignancies. J Transl Med (2016) 0.75
Mutational landscape and underlying mutational processes in chronic lymphocytic leukemia. Mol Cell Oncol (2016) 0.75
The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia. PLoS One (2017) 0.75
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer. Nat Genet (2017) 0.75
TopHat: discovering splice junctions with RNA-Seq. Bioinformatics (2009) 81.13
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc (2012) 35.75
Signatures of mutational processes in human cancer. Nature (2013) 21.63
Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature (2013) 20.16
Initial genome sequencing and analysis of multiple myeloma. Nature (2011) 17.28
Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell (2011) 16.72
Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med (2000) 16.30
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol (2013) 16.13
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature (2011) 13.18
Discovery and saturation analysis of cancer genes across 21 tumour types. Nature (2014) 11.68
Mutational processes molding the genomes of 21 breast cancers. Cell (2012) 11.22
Clonal evolution in cancer. Nature (2012) 11.07
Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol (2012) 10.87
Diverse somatic mutation patterns and pathway alterations in human cancers. Nature (2010) 10.83
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell (2013) 9.24
Punctuated evolution of prostate cancer genomes. Cell (2013) 7.23
Molecular mechanisms of antibody somatic hypermutation. Annu Rev Biochem (2007) 6.92
Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature (2001) 6.70
Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem (1999) 6.67
Germinal centers. Annu Rev Immunol (2012) 6.26
A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries. Genome Biol (2011) 5.11
Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. Mol Cell (2012) 4.52
Chromothripsis from DNA damage in micronuclei. Nature (2015) 4.04
DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nat Immunol (2001) 4.00
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest (2005) 3.99
Deciphering signatures of mutational processes operative in human cancer. Cell Rep (2013) 3.61
RNA-SeQC: RNA-seq metrics for quality control and process optimization. Bioinformatics (2012) 2.94
ContEst: estimating cross-contamination of human samples in next-generation sequencing data. Bioinformatics (2011) 2.90
Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes. Nat Immunol (2010) 2.80
Criteria for inference of chromothripsis in cancer genomes. Cell (2013) 2.51
Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. Blood (2006) 2.36
Passenger transgenes reveal intrinsic specificity of the antibody hypermutation mechanism: clustering, polarity, and specific hot spots. Proc Natl Acad Sci U S A (1993) 2.30
Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. Blood (2013) 1.84
Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability. Genome Res (2012) 1.82
Hypermutation in human cancer genomes: footprints and mechanisms. Nat Rev Cancer (2014) 1.67
Molecular pathogenesis of chronic lymphocytic leukemia. J Clin Invest (2012) 1.64
Complex regulation and function of activation-induced cytidine deaminase. Trends Immunol (2011) 1.36
Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia. Clin Cancer Res (2012) 1.33
Regulation of AID, the B-cell genome mutator. Genes Dev (2013) 1.21
Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone. Blood (2003) 1.20
Muscarinic receptor subtype-3 gene ablation and scopolamine butylbromide treatment attenuate small intestinal neoplasia in Apcmin/+ mice. Carcinogenesis (2011) 1.16
Complementation of defective translesion synthesis and UV light sensitivity in xeroderma pigmentosum variant cells by human and mouse DNA polymerase eta. Nucleic Acids Res (2000) 1.16
Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation. Blood (2003) 1.12
Recurrent targets of aberrant somatic hypermutation in lymphoma. Oncotarget (2012) 1.11
Activation of Robo1 signaling of breast cancer cells by Slit2 from stromal fibroblast restrains tumorigenesis via blocking PI3K/Akt/β-catenin pathway. Cancer Res (2012) 1.11
Regulation of Aicda expression and AID activity. Autoimmunity (2013) 1.11
Uracil in DNA and its processing by different DNA glycosylases. Philos Trans R Soc Lond B Biol Sci (2009) 1.10
Ectopic restriction of DNA repair reveals that UNG2 excises AID-induced uracils predominantly or exclusively during G1 phase. J Exp Med (2012) 1.00
Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood (2000) 0.99
Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms. Br J Haematol (2010) 0.98
Transcriptional pausing and stalling causes multiple clustered mutations by human activation-induced deaminase. FASEB J (2008) 0.96
AID expression in B-cell lymphomas causes accumulation of genomic uracil and a distinct AID mutational signature. DNA Repair (Amst) (2014) 0.95
Automatic relevance determination in nonnegative matrix factorization with the β-divergence. IEEE Trans Pattern Anal Mach Intell (2013) 0.93
IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions. Blood (2012) 0.91
Novel insights into the biology of CLL. Hematology Am Soc Hematol Educ Program (2010) 0.91
Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients. Blood (2014) 0.90
Cancer gene discovery: exploiting insertional mutagenesis. Mol Cancer Res (2013) 0.88
Frequency of 5'IGH deletions in B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet (2009) 0.86
APOBEC3 signature mutations in chronic lymphocytic leukemia. Leukemia (2014) 0.86
Aberrant methylation and loss of CADM2 tumor suppressor expression is associated with human renal cell carcinoma tumor progression. Biochem Biophys Res Commun (2013) 0.85
AID induces intraclonal diversity and genomic damage in CD86(+) chronic lymphocytic leukemia cells. Eur J Immunol (2014) 0.84
Analysis of Ig gene hypermutation in Ung(-/-)Polh(-/-) mice suggests that UNG and A:T mutagenesis pathway target different U:G lesions. Mol Immunol (2012) 0.81
Independent coexistence of clones with 13q14 deletion at reciprocal translocation breakpoint and 13q14 interstitial deletion in chronic lymphocytic leukemia. Leuk Lymphoma (2012) 0.76